[Seroepidemiologic studies in 63 patients given organ transplants in relation to cytomegalovirus, herpes simplex, varicella-zoster and HTLV-III: validity and limits].
We carried out a seroepidemiological study on 63 patients undergoing organ transplantation in order to determine viral markers like CMV, HTLV III, HS and V/Z. The antibodies valuation was carried out by enzyme-linked immunosorbent assays (ELISA-Abbott) and complement fixation test. All the tested markers give a high percentage of positivity even if the values relevant to anti-HTLV III antibodies can not be related to infection but, probably, to anti-HLA-Dr antibodies.
Lilli
D
D
II Cattedra di Microbiologia, Università La Sapienza, Roma.
Lorino
G
G
Cipriani
P
P
Berloco
P
P
Pretagostini
R
R
Mancini
C
C
D003587:Cytomegalovirus / Q000302:isolation & purification; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000453:epidemiology*; D014645:Herpesvirus 3, Human / Q000302:isolation & purification; D006801:Humans; D007158:Immunologic Techniques; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D006435:Renal Dialysis; D018139:Simplexvirus / Q000302:isolation & purification; D014180:Transplantation
Indagine sieroepidemiologica in 63 pazienti sottoposti a trapianto di organo nei confronti del cytomegalovirus, dell'herpes simplex, del varicella/zoster e dell'HTLV III: validità e limiti.